Endometriosis Market By Reports And Data
                     Endometriosis 
Market To Reach 
USD 2.42 Billion 
By 2026
              Markett  Summary
Increasing awareness about women's health, increasing occurrence rate of the condition, the rising 
focus on clinical trials are some of the factors boosting the endometriosis market. 
Market Size – USD 1.93 Billion in 2018, Market Growth - CAGR of 2.8%, Market Trends –The 
increasing focus on clinical trial.
The Global endometriosis market is forecast to reach USD 2.42 Billion by 2026, according to a new 
report by Reports and Data. Endometriosis is the resultant of the growth of endometrial tissue on 
bowel, ovaries, and tissues lining the pelvis. The hormonal changes associated with the menstrual 
cycle impacts the misplaced endometrial tissue that results in the area to become inflamed that 
causes pain. It implies that the tissue will thicken, grow, and break down. With time, the tissue that 
broken down has nowhere to go and becomes trapped in pelvis.
www.reportsanddata.com
Further key findings from the report suggest
• In regards to the End-users, the Drugstores segment can be seen to occupy the largest market 
share of 30.2% in 2018, with the second-highest growth rate of 3.1% during the forecast period. 
The fact that in most cases of endometriosis, pain in the primary issue, in which medication is 
the first choice, has resulted in high dependency on drugstores for availing the prescribed 
medication, which contributes to the market share occupied by this segment.
• The endometriosis market held a market share of USD 1.93 Billion in the year 2018 and 
forecasted to grow at a rate of 2.8% during the forecast period.
• In regards to Drug Type, the NSAID’s segment generated the highest revenue of USD 0.58 Billion 
in 2018, with a growth rate of 2.9% during the forecast period. The effectiveness of the medicine 
in relieving pain caused by the condition, which are nonsteroidal anti-inflammatory drugs that 
work by discontinuing the release of prostaglandins that is one of the main chemicals resulting in 
the pain, contributes to the revenue generated by the NSAID’s segment.
• In context to Surgery Type, the Laparoscopy segment yielded the highest revenue of USD 0.87 
Billion in 2018, with the fastest growth rate of 3.2% during the forecast period. The effectiveness 
of this surgery in accurately diagnosing endometriosis and even eliminate it in mild-moderate 
condition with just a small incision resulted in its increased demand and revenue generated by 
the    
              Markett  Summary
Key Players:   
Johnson & Johnson Services Inc., Bayer AG, Neurocrine Biosciences Inc., Meditrina Pharmaceuticals Inc., AbbVie 
Inc., Astellas Pharma Inc., AstraZeneca Plc, Evotec AG, Debiopharm Group and Teva Pharmaceutical Industries Ltd.
Segmentation:
For the purpose of this report, Reports and Data have segmented the global endometriosis market based on 
Surgery Type, Drug Type, End-Users, and region:
Surgery Type Outlook (Revenue, USD Billion; 2016-2026)
• Laparoscopy
• Laparotomy
• Pelvic nerves surgery
Drug Type Outlook (Revenue, USD Billion; 2016-2026)
• NSAID’s
• Gonadotropins Releasing Hormone Agonists
• Progestin
• Oral Contraceptive Pills
To look at the PDF Sample Report and get 30 minutes of a free consultation @ https://
www.reportsanddata.com/sample-enquiry-form/2553
www.reportsanddata.com
              Markett  Summary
End-Users Type Outlook (Revenue, USD Billion; 2016-2026)
• Hospital
• Pharmacies
• Drugstores
• E-commerce
Regional Outlook (Revenue, USD Billion; 2016-2026)
• North America
• Europe
• Asia Pacific
• MEA
• Latin America
View press release for more information @ https://
www.globenewswire.com/news-release/2020/03/05/1996125/0/en/Endo
metriosis-Market-To-Reach-USD-2-42-Billion-By-2026-Reports-And-Data.h
tml
www.reportsanddata.com
              The  reportt  emphasiizes  tthe  ffollllowiing  key  questtiions::
Q.1.What are the most lucrative and promising growth prospects for the market?
Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects 
come into play in this advancement?
Q.3.Which geographies are estimated to exhibit the highest growth and the underlying 
causes?
Q.4.Which factors are impacting the future of the market and what are the driving 
factors?
Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast 
period?
www.reportsanddata.com
About Us
Reports and Data is a market research and consulting company that provides 
syndicated research reports, customized research reports, and consulting services. 
Our solutions purely focus on your purpose to locate, target and analyze consumer 
behavior shifts across demographics, across industries and help client’s make a 
smarter business decision. We offer market intelligence studies ensuring relevant 
and fact-based research across a multiple industries including Healthcare, 
Technology, Chemicals, Power, and Energy. We consistently update our research 
offerings to ensure our clients are aware about the latest trends existent in the 
market. Reports and Data has a strong base of experienced analysts from varied 
areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]